Cervical Cancer – Preventable, Detectable, Treatable
Cancer of the cervix is the 4th most common cancer among women worldwide with estimated 527,624 new cases and 265,672 death in 2012 (GLOBOCAN). According to ICO Information Centre on HPV & Cancer 2017, about 2,145 new cervical cancer cases are diagnosed annually in Malaysia in 2012. Cervical cancer ranks as 2nd leading cause of female cancer in Malaysia & the 2nd most common female cancer in women aged 15 to 44 years in Malaysia. About 621 cervical cancer death occur annually in Malaysia in 2012.
宫颈癌是全球女性中第四大常见的癌症。在2012年，新增病例为527,624例及死亡病例为265,672例。根据 ICO Information Centre on HPV & Cancer 2017，马来西亚在2012年，每年诊断出大约2,145例宫颈癌新病例。宫颈癌排位马来西亚女性癌症第二位，它也是马来西亚15至44岁的女性中第二普遍的女性癌症。在2012年，马来西亚每年约有621宗宫颈癌死亡病例。
Human papillomavirus (HPV) infection is now a well-established cause of cervical cancer & there is growing evidence of HPV being a relevant factor in other anogenital cancers (anus, vulva, vagina & penis) as well as head & neck cancers. HPV type 16 & 18 are responsible for about 70% of all cervical cancer cases worldwide. HPV vaccine that prevent HPV 16 & 18 infection are now available & have the potential to reduce the incidence of cervical & other anogenital cancers.
人乳头状瘤病毒（HPV）感染已经被确定为导致宫颈癌的因素。越来越多的证据显示，HPV也是其他肛门生殖器癌症如肛门、外阴、阴道和阴茎，以及头颈部癌症的相关因素。全世界约70%的宫颈癌病例都是由HPV 16和18型导致的。HPV疫苗可以预防HPV 16和18型病毒，有效的降低宫颈癌地发病率及其他肛门生殖器癌症。
Cervical cancer develops over time, it is also one of the most preventable types of cancer. Precancerous cervical cell changes & early cancers of the cervix generally do not cause symptoms. For this reason, regular screening through Pap & HPV tests can help catch precancerous cell changes early & prevent the development of cervical cancer. Get yourselves vaccinated for prevention. Widespread immunization with the HPV vaccine could reduce the impact of cervical cancer worldwide.
宫颈癌的病发进展缓慢，因此它并非不治之症，而且它也是最可预防的癌症之一。宫颈癌癌前细胞病变和早期的癌症通常不会引起症状。因此，通过定期进行子宫颈膜片和HPV检测可以帮助提早发现癌前细胞病变，并预防宫颈癌的发生。
现在就让自己接受宫颈癌疫苗注射，以预防宫颈癌。广泛的HPV疫苗接种将可以减少全球的宫颈癌。
